# Prospective Study to Evaluate the Clinical Utility of Perioperative Pharmacogenomic Testing

> **NCT03531268** · NA · WITHDRAWN · sponsor: **Brigham and Women's Hospital**

## Conditions studied

- Perioperative/Postoperative Complications

## Interventions

- **OTHER:** PGx Testing

## Key facts

- **NCT ID:** NCT03531268
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-10-20
- **Primary completion:** 2020-05-20
- **Final completion:** 2020-05-20
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Need improve the strategy
- **Last updated:** 2019-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03531268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03531268, "Prospective Study to Evaluate the Clinical Utility of Perioperative Pharmacogenomic Testing". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03531268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*